Ídra, Greece Health News, Events and Opinion on Allvoices
Front Page

Ídra Health News

Source: Bidness etc.

Ídra :: Greece | updated 2014-04-08 06:54:43 -0700 | health-news

Toll-like Receptor (TLR) antagonist, IMO-8400, is able to inhibit the spread and survival of B-cell lymphoma cells that carry the oncogenic MYD88 L265P genetic mutation. The data adds to the company's compilation and brings it closer to commercializing IMO-8400, which...
Views: 0   News Stories: 0
Blog Posts: 0 0 0 0

Build Your Allvoices Brand. Gain Influence. Make Money.

Join the Build Your Allvoices Brand Incentive Program

Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc. 2008-2014. All rights reserved. Powered by PulsePoint.